Zhou C - Search Results

1

Reduced expression of PER3 is associated with incidence and development of colon cancer.

Wang X, Yan D, Teng M, Fan J, Zhou C, Li D, Qiu G, Sun X, Li T, Xing T, Tang H, Peng X, Peng Z. Wang X, et al. Among authors: zhou c. Ann Surg Oncol. 2012 Sep;19(9):3081-8. doi: 10.1245/s10434-012-2279-5. Epub 2012 Feb 17. Ann Surg Oncol. 2012. PMID: 22350604

2

Gene-expression profiling in Chinese patients with colon cancer by coupling experimental and bioinformatic genomewide gene-expression analyses: identification and validation of IFITM3 as a biomarker of early colon carcinogenesis.

Fan J, Peng Z, Zhou C, Qiu G, Tang H, Sun Y, Wang X, Li Q, Le X, Xie K. Fan J, et al. Among authors: zhou c. Cancer. 2008 Jul 15;113(2):266-75. doi: 10.1002/cncr.23551. Cancer. 2008. PMID: 18470904 Free article.

3

Inhibition of the growth and metastasis of human colon cancer by restoration of RUNX3 expression in cancer cells.

Peng Z, Tang H, Wang X, Zhou C, Fan J, Wang L, Jia Z, Li Q, Le X, Wei D, Xie K. Peng Z, et al. Among authors: zhou c. Int J Oncol. 2008 Nov;33(5):979-84. Int J Oncol. 2008. PMID: 18949360

4

IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.

Li D, Yan D, Tang H, Zhou C, Fan J, Li S, Wang X, Xia J, Huang F, Qiu G, Peng Z. Li D, et al. Among authors: zhou c. Ann Surg Oncol. 2009 Dec;16(12):3499-506. doi: 10.1245/s10434-009-0648-5. Ann Surg Oncol. 2009. PMID: 19672661

5

Digital transcript profile analysis with aRNA-LongSAGE validates FERMT1 as a potential novel prognostic marker for colon cancer.

Fan J, Yan D, Teng M, Tang H, Zhou C, Wang X, Li D, Qiu G, Peng Z. Fan J, et al. Among authors: zhou c. Clin Cancer Res. 2011 May 1;17(9):2908-18. doi: 10.1158/1078-0432.CCR-10-2552. Epub 2011 Jan 10. Clin Cancer Res. 2011. PMID: 21220475

6

Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery.

Wen Y, Wang Q, Zhou C, Yan D, Qiu G, Yang C, Tang H, Peng Z. Wen Y, et al. Among authors: zhou c. Ann Surg Oncol. 2011 Dec;18(13):3858-67. doi: 10.1245/s10434-011-1668-5. Epub 2011 Mar 26. Ann Surg Oncol. 2011. PMID: 21442347

7

Phospholipase C epsilon plays a suppressive role in incidence of colorectal cancer.

Wang X, Zhou C, Qiu G, Yang Y, Yan D, Xing T, Fan J, Tang H, Peng Z. Wang X, et al. Among authors: zhou c. Med Oncol. 2012 Jun;29(2):1051-8. doi: 10.1007/s12032-011-9981-1. Epub 2011 Jun 11. Med Oncol. 2012. PMID: 21667163

8

Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer.

Zhu X, Han Y, Yuan C, Tu W, Qiu G, Lu S, Lu H, Peng Z, Zhou C. Zhu X, et al. Among authors: zhou c. Oncol Rep. 2015 Jan;33(1):320-8. doi: 10.3892/or.2014.3559. Epub 2014 Oct 22. Oncol Rep. 2015. PMID: 25338725

9

Period 1 and estrogen receptor-beta are downregulated in Chinese colon cancers.

Wang Y, Xing T, Huang L, Song G, Sun X, Zhong L, Fan J, Yan D, Zhou C, Cui F, Yu F, Chen J, Yu Y, Li C, Tang H, Peng Z, Wang X. Wang Y, et al. Among authors: zhou c. Int J Clin Exp Pathol. 2015 Jul 1;8(7):8178-88. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26339386 Free PMC article.

10

Decreased MALL expression negatively impacts colorectal cancer patient survival.

Wang X, Fan J, Yu F, Cui F, Sun X, Zhong L, Yan D, Zhou C, Deng G, Wang B, Qi X, Wang S, Qu L, Deng B, Pan M, Chen J, Wang Y, Song G, Tang H, Zhou Z, Peng Z. Wang X, et al. Among authors: zhou z, zhou c. Oncotarget. 2016 Apr 19;7(16):22911-27. doi: 10.18632/oncotarget.8094. Oncotarget. 2016. PMID: 26992238 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,844 results

Search Page

Filters